Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study
- PMID: 27357355
- DOI: 10.1093/eurheartj/ehw250
Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study
Abstract
Introduction: Stratification for subsequent coronary events among patients with coronary artery disease (CAD) is of considerable interest because of the potential to guide secondary preventive therapies. Recently, we identified eight microRNAs (miRNAs), which facilitated acute coronary syndrome (ACS) diagnosis. In this study, we aimed to evaluate their potential role as prognostic biomarkers for cardiovascular disease.
Methods: The serum concentrations of eight candidate miRNAs -miR-19a, miR-19b, miR-132, miR-140-3p, miR-142-5p, miR-150, miR-186, and miR-210 were measured in a cohort of 1112 patients with documented CAD-including 430 patients with ACS and 682 patients with stable angina pectoris. Cardiovascular death was the main outcome measure.
Results: During a median follow-up of 4.0 years, most miRNAs reliably predicted cardiovascular death in ACS patients. Cox regression analyses indicated that in particular miR-132 (HR 2.85 per 1 SD increase, P = 0.022), miR-140-3p (HR 2.88 per 1 SD increase, P = 0.022), and miR-210 (HR 3.10 per 1 SD increase, P = 0.039) were able to precisely predict cardiovascular death. Circulating miR-132, miR-140-3p, and miR-210 clearly improved various model performance measures, including C-statistics (AUC [area under the receiver-operating characteristic curve] for miR-132: 0.737; AUC for miR-140-3p: 0.756; AUC for miR-210: 0.754).
Conclusions: This is the largest study so far evaluating the prognostic value of circulating miRNAs in cardiovascular disease. Our study shows that single miRNAs derived from peripheral blood predict mortality in secondary prevention settings, and thereby represent valuable biomarkers for risk estimation in CAD.
Keywords: Biomarker; Coronary artery disease; MicroRNA; Prognosis.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2016. For permissions please email: journals.permissions@oup.com.
Comment in
-
Zooming in on microRNAs for refining cardiovascular risk prediction in secondary prevention.Eur Heart J. 2017 Feb 14;38(7):524-528. doi: 10.1093/eurheartj/ehw259. Eur Heart J. 2017. PMID: 27371715 No abstract available.
-
Circulating microRNA biomarkers for cardiovascular risk prediction: are we approaching clinical application?Ann Transl Med. 2016 Dec;4(24):490. doi: 10.21037/atm.2016.12.05. Ann Transl Med. 2016. PMID: 28149852 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous